Core Insights - Nanyang, located in southern Henan, has a strong foundation for biomass manufacturing and energy conversion, with over 30 million tons of biomass raw materials produced annually, including over 10 million tons of crop straw and over 10 million livestock [1] - The "2025 Nanyang Synthetic Biology Industry Conference" established the "Central Plains Synthetic Biology Industry-Academia-Research Innovation Alliance" and released the "Biomanufacturing Pilot Zone Action Plan" 1.0, aiming to develop a trillion-level synthetic biology industry cluster [1][5] - The synthetic biology industry in Nanyang has a solid demand foundation, with Muyuan, a leading pig farming company, driving the development of synthetic biology technology through cost reduction initiatives [1][3] Company Developments - In 2023, Muyuan partnered with Westlake University to establish the Nanyang Westlake Muyuan Synthetic Biology Research Institute and Muyuan Laboratory, focusing on producing small amino acids through synthetic biology technology [2] - Muyuan's production of synthetic biological products has commenced, with an annual output of 30,000 tons, promoting the industrialization of amino acid biosynthesis technology [2] Financial Performance - Muyuan's 2025 mid-year performance forecast indicates a net profit of 10.2 billion to 10.7 billion yuan, representing a year-on-year increase of 1129.97% to 1190.26% [3] - The company expects a non-net profit of 10.6 billion to 11.1 billion yuan, reflecting a year-on-year growth of 882.95% to 929.31% [3] - The significant increase in performance is attributed to a rise in pig output and a decrease in breeding costs, with the total cost of pig farming dropping from 13.1 yuan/kg at the beginning of the year to below 12.1 yuan/kg by June [3] Industry Trends - The application of synthetic biology technology in the livestock industry is just a small part of its potential, with future applications expected in materials, agricultural technology, food, and healthcare [4] - Nanyang is developing a comprehensive industrial support service system, focusing on energy integration and logistics to further reduce production costs [4][6] - The region aims to focus on key areas such as feed amino acid substitution, biomedicine, and bio-based materials, driving the entire industry chain upgrade through breakthroughs in synthetic biology [6]

Core Insights - The article discusses the potential of synthetic biology to address various global challenges, including energy security, food safety, and mental health issues [1][3][4]. Group 1: Synthetic Biology Overview - Synthetic biology is presented as a solution to resource scarcity and environmental pollution, with a focus on sustainable utilization of natural resources [3][4]. - The evolution of biotechnology is outlined, from natural fermentation (first generation) to directed fermentation (second generation) and finally to synthetic biology (third generation), which involves designing and modifying microorganisms for specific human needs [3][4]. Group 2: Future Applications and Innovations - The concept of "cell factories" is introduced, where high-yield crops like corn and wheat serve as fermentation raw materials, and genetically modified strains are used to produce desired substances [4]. - Future advancements may allow for the synthesis of materials directly from atmospheric nitrogen and carbon dioxide, eliminating the need for traditional agricultural inputs [4]. Group 3: Ethical Considerations and Public Engagement - Ethical concerns regarding the misuse of synthetic biology, such as cloning and the revival of extinct species, are highlighted, emphasizing the need for cautious research and public consensus on boundaries [9]. - The engagement of young students in discussions about synthetic biology reflects a growing interest in the field, with imaginative ideas about potential applications, such as creating hybrid fruits or reviving extinct animals [5][7][9].

Core Viewpoint - The article emphasizes the importance of biomanufacturing as a key focus for enhancing economic competitiveness in various countries, including China, which is advancing its manufacturing capabilities through initiatives like green manufacturing and intelligent manufacturing [1]. Group 1: Event Overview - The Fourth Synthetic Biology and Green Biomanufacturing Conference (SynBioCon 2025) will be held from August 20-22 in Ningbo, Zhejiang, focusing on the integration of AI and biomanufacturing, along with four major application areas: green chemicals and new materials, future food, future agriculture, and beauty raw materials [1]. - The conference aims to explore the development trends of the biomanufacturing industry during the 14th Five-Year Plan period and identify innovative technologies and products that will sustain the industry's vitality [1]. Group 2: Organizing Institutions - The conference is organized by Ningbo Detaizhong Research Information Technology Co., Ltd. (DT New Materials) and co-organized by Ningbo Meisai Biological Engineering Co., Ltd. It is supported by various professional committees and alliances in the field of biomanufacturing [2]. Group 3: Highlights of the Conference - The conference will feature forums and closed-door activities to gain insights into the development trends of biomanufacturing, explore new products and technologies, and foster new collaborations [4]. - There will be over 100 financing project roadshows to discover new cooperation opportunities and showcase innovative technological achievements [4]. - Key industry leaders, top universities, capital from parks, and the entire industry chain will gather to discuss advancements and opportunities in biomanufacturing [4]. Group 4: Agenda and Activities - The first day will include a closed-door seminar focusing on the development trends and growth points of biomanufacturing during the 14th Five-Year Plan, inviting 30 industry leaders and experts for in-depth discussions [9]. - The second and third days will feature a macro forum on biomanufacturing, specialized sub-forums on green chemicals, AI in biomanufacturing, future food and agriculture, and beauty raw materials, addressing various key topics and innovations in these fields [13]. - A special session for showcasing scientific achievements and project matchmaking will also be held, inviting 100 innovative projects in the biomanufacturing sector for display and collaboration [14].

Core Viewpoint - The article emphasizes the importance of biomanufacturing as a key focus for enhancing economic competitiveness in various countries, including China, which is advancing its manufacturing capabilities through initiatives like green manufacturing and intelligent manufacturing [1]. Group 1: Event Overview - The Fourth Synthetic Biology and Green Biomanufacturing Conference (SynBioCon 2025) will be held from August 20-22 in Ningbo, Zhejiang, focusing on the integration of AI and biomanufacturing [1]. - The conference aims to explore the development trends of the biomanufacturing industry during the 14th Five-Year Plan and identify innovative technologies and products that will sustain the industry's vitality [1]. Group 2: Organizing Institutions - The conference is organized by Ningbo Detaizhong Research Information Technology Co., Ltd. (DT New Materials) and supported by various institutions, including the Chinese Society of Biotechnology and the Zhejiang Synthetic Biology Industry Technology Alliance [2]. Group 3: Conference Highlights - Key highlights include forums and closed-door discussions on biomanufacturing trends, youth innovation technology sharing, and over 100 financing project roadshows to discover new cooperation opportunities [4]. - The event will gather leading enterprises, top universities, investment institutions, and industry stakeholders to foster collaboration [4]. Group 4: Agenda and Activities - The first day features a closed-door seminar focusing on the development trends and growth points of biomanufacturing, inviting 30 industry leaders and experts for in-depth discussions [9]. - The second and third days will include a macro forum on biomanufacturing, specialized sub-forums on green chemicals, AI in biomanufacturing, future food and agriculture, and beauty raw materials [13]. Group 5: Specialized Topics - Sub-forums will cover various topics, including the development of bio-based chemicals, AI applications in enzyme discovery, and the biomanufacturing of high-value food ingredients [13]. - The conference will also showcase innovative projects and facilitate connections between research teams and industry players [12][14].

Core Viewpoint - The article emphasizes the importance of biomanufacturing as a key focus for enhancing economic competitiveness in various countries, including China, which is advancing its manufacturing capabilities through synthetic biology initiatives [1]. Group 1: Event Overview - The Fourth Synthetic Biology and Green Biomanufacturing Conference (SynBioCon 2025) will be held from August 20-22 in Ningbo, Zhejiang, focusing on the integration of AI and biomanufacturing, along with four application areas: green chemicals and new materials, future food, future agriculture, and beauty raw materials [1]. - The conference aims to explore the development trends of the biomanufacturing industry during the 14th Five-Year Plan, identify innovative technologies and products, and promote the transfer and commercialization of scientific achievements [1]. Group 2: Organizing Institutions - The conference is organized by Ningbo Detaizhong Research Information Technology Co., Ltd. (DT New Materials) and supported by various institutions, including the Chinese Society of Biotechnology and the Zhejiang Synthetic Biology Industry Technology Alliance [2]. Group 3: Conference Highlights - Key highlights include forums and closed-door activities to gain insights into the biomanufacturing development trends, sharing of innovative technologies, and over 100 financing project roadshows to discover new cooperation opportunities [2]. - The event will also feature a youth innovation technology forum to connect talents and share valuable insights [2]. Group 4: Conference Agenda - The first day will include a closed-door seminar focusing on the development trends and growth points of biomanufacturing, inviting 30 industry leaders and experts for in-depth discussions [7]. - The second and third days will feature a macro forum on the biomanufacturing industry, covering various specialized topics such as green chemicals, AI in biomanufacturing, future food and agriculture, and beauty raw materials [10][12]. Group 5: Specialized Topics - Specialized forums will address topics like the development of bio-based chemicals, AI applications in enzyme discovery, and the biomanufacturing of high-value food ingredients [10][11]. - The conference will also showcase innovative projects and technologies in the field of synthetic biology and biomanufacturing, encouraging participation from research institutions and enterprises [12].

Core Viewpoint - The article emphasizes the importance of biomanufacturing as a key focus for enhancing economic competitiveness in various countries, including China, which is advancing its manufacturing capabilities through initiatives like green manufacturing and intelligent manufacturing [1]. Group 1: Event Overview - The Fourth Synthetic Biology and Green Biomanufacturing Conference (SynBioCon 2025) will be held from August 20-22 in Ningbo, Zhejiang, focusing on the integration of AI and biomanufacturing [1]. - The conference aims to explore the development trends of the biomanufacturing industry during the 14th Five-Year Plan, discussing innovative technologies and products that can sustain the industry's vitality [1]. Group 2: Organizing Institutions - The conference is organized by Ningbo Detai Zhongyan Information Technology Co., Ltd. (DT New Materials) and co-organized by Ningbo Meisai Biological Engineering Co., Ltd. [2]. - Supporting organizations include the Chinese Society of Biotechnology's Biobased Materials Committee and various local industry alliances [2]. Group 3: Highlights of the Conference - The conference will feature forums and closed-door activities to gain insights into the development trends of biomanufacturing and explore new products, technologies, and collaborations [5]. - There will be over 100 financing project roadshows to discover new cooperation opportunities [5]. - Key industry leaders, top universities, and investment institutions will gather to discuss advancements in the biomanufacturing sector [5]. Group 4: Agenda and Activities - The first day will include a closed-door seminar focusing on the development trends and growth points of biomanufacturing [10]. - The second and third days will feature a macro forum on biomanufacturing, specialized sub-forums on green chemicals, AI in biomanufacturing, future food and agriculture, and beauty raw materials [14]. - A special session for showcasing scientific achievements and project matchmaking will also be held, inviting innovative projects from the biomanufacturing field [15].

Group 1: Forum Overview - The 2025 Changping Pharmaceutical Health Financial Investment Innovation Forum was successfully held to promote the development of China's pharmaceutical health industry and enhance Changping's status as an innovation hub [1][2] - The forum featured 18 prominent guests and nearly 200 participants from academia, industry, healthcare, and investment sectors, discussing industry development and capital support [2] Group 2: Government and Financial Support - Beijing State-owned Capital Operation Management Co., Ltd. is actively supporting the pharmaceutical health industry through capital layout optimization and industry transformation, establishing a 100 billion yuan municipal government investment fund [3] - The Beijing Pharmaceutical Health Industry Investment Fund, with a scale of 20 billion yuan, was established in Changping in 2024, focusing on innovative drugs and medical devices [3] - As of mid-2025, the fund has invested over 4 billion yuan, attracting more than 5 billion yuan in social investment [3] Group 3: Innovation and Technology Integration - AI technology is becoming a key driver for the clinical transformation of regenerative medicine, addressing challenges such as individual variability and complex tissue construction [4] - The integration of AI in drug development is reshaping the pharmaceutical industry, with platforms like PandaOmics and Chemistry42 enhancing efficiency in target discovery and molecular design [8] Group 4: Industry Trends and Future Outlook - China's pharmaceutical industry is transitioning from policy-driven to capability-driven, with a significant increase in innovative drug approvals expected by 2024 [7] - The market for innovative drugs in China is projected to exceed 300 billion USD by 2030, with a growing global market share [7] - The domestic medical device industry is accelerating its globalization, with increasing independence from foreign technologies and a focus on high-end medical equipment [11]

Core Viewpoint - The article emphasizes the importance of biomanufacturing as a key focus for enhancing economic competitiveness in various countries, including China, which is advancing its manufacturing capabilities through initiatives like green manufacturing and intelligent manufacturing [1]. Group 1: Event Overview - The Fourth Synthetic Biology and Green Biomanufacturing Conference (SynBioCon 2025) will be held from August 20-22 in Ningbo, Zhejiang, focusing on the integration of AI and biomanufacturing [1]. - The conference aims to explore the development trends of the biomanufacturing industry during the 14th Five-Year Plan, discussing innovative technologies and products that can sustain the industry's vitality [1]. Group 2: Organizing Institutions - The conference is organized by Ningbo Detaizhong Research Information Technology Co., Ltd. (DT New Materials) and co-organized by Ningbo Meisai Bioengineering Co., Ltd. [2]. - Supporting organizations include the Chinese Society of Biotechnology's Biobased Materials Committee and various local industry alliances [2]. Group 3: Highlights of the Conference - The conference will feature forums and closed-door activities to gain insights into the development trends of biomanufacturing and explore new products, technologies, and collaborations [5]. - There will be over 100 financing project roadshows to discover new cooperation opportunities [5]. - Key players from leading enterprises, top universities, investment institutions, and industry stakeholders will gather to discuss advancements in the field [5]. Group 4: Agenda and Activities - The first day will include a closed-door seminar focusing on the development trends and growth points of biomanufacturing [10]. - The second and third days will feature a macro forum on biomanufacturing, specialized sub-forums on green chemicals, AI in biomanufacturing, future food and agriculture, and beauty raw materials [14]. - The conference will also host a technology achievement showcase to promote innovative results and projects in the biomanufacturing sector [15].

Core Viewpoint - The fourth Synthetic Biology and Green Bio-Manufacturing Conference (SynBioCon 2025) will be held from August 20-22 in Ningbo, Zhejiang, focusing on industrial ecological development and the transfer of scientific achievements [1][10]. Group 1: Conference Overview - SynBioCon 2025 is organized by DT New Materials and supported by various organizations, aiming to facilitate over 1,000 connections between research institutions and startup projects [1]. - The conference will feature a special event showcasing 100 innovative achievements in synthetic biology manufacturing, promoting efficient technology transfer [1][9]. Group 2: Featured Project - The project "Synthesis of Selenium Protein from Microalgae" aims to address the issue of selenium deficiency in the Chinese population by using edible microalgae as a source of selenium protein [6]. - The research team has successfully transferred human selenium protein into the edible microalgae Chlorella vulgaris and has significantly increased the yield through optimized cultivation parameters [7]. Group 3: Technical Advantages - Chlorella vulgaris is recognized as a safe and reliable food source, approved by the National Health Commission, and can be cultivated through both photosynthesis and industrial fermentation [7]. - The project is currently in the pilot production stage after successful small-scale trials [7]. Group 4: Intellectual Property and Collaboration - The project is in the process of patent application, with potential collaboration modes including joint development, technology transfer, or intellectual property transfer [8]. Group 5: Industry Focus - The conference will explore the trends in the bio-manufacturing industry, focusing on AI and biological manufacturing, green chemicals, new materials, future food, future agriculture, and beauty raw materials [10].

Core Viewpoint - The article highlights the approval of alulose by the National Health Commission, marking the first instance of a company using synthetic biology to produce this new food ingredient in China [1][2]. Group 1: Approval and Technology - The AS10 strain fermentation method for producing alulose is the first case in China to receive approval for a new food ingredient using synthetic biology technology [2]. - The unique "one-step fermentation" process developed by the company simplifies production and enhances product quality compared to traditional methods [2][3]. Group 2: Cost Reduction and Market Potential - Previously, alulose production required a two-step conversion with an efficiency of only about 10%, leading to high market prices around 30,000 yuan per ton [4]. - With the optimization of synthetic biology technology, production costs are expected to decrease by 50%, potentially lowering prices to around 10,000 yuan per ton, which would significantly expand its market applications [5]. Group 3: Production Capacity and Future Plans - The company's first-phase alulose factory in Qinhuangdao has commenced operations, and a second-phase factory is set to begin production in 2027 [7]. - The company is also collaborating with traditional bio-manufacturing partners to upgrade multiple production capacities, with a 60,000-ton capacity project in North China expected to be operational by October 2025, positioning the company as the largest alulose supplier globally [8].